Back to Search
MICHAEL BOECKH, MD
MD
Infectious Disease Physician
NPI: 1033310222Individual
Specialties, Licenses & Credentials
Infectious Disease PhysicianPrimary
Internal Medicine — Infectious Disease
Code: 207RI0200X
MD00031422(WA)
Research & Publications (20)
How we treat cytomegalovirus in hematopoietic cell transplant recipients.
PMID 19299333·Blood·2009
6-review
The challenge of respiratory virus infections in hematopoietic cell transplant recipients.
PMID 18785968·Br J Haematol·2008
6-review
Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.
PMID 17173225·Clin Infect Dis·2007
4-observational
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study.
PMID 16282339·Blood·2006
2-rct
Prevention of VZV infection in immunosuppressed patients using antiviral agents.
PMID 17147908·Herpes·2006
6-review
Rising CMV PP65 antigenemia and DNA levels during preemptive antiviral therapy.
PMID 15820936·Haematologica·2005
8-other
Emerging viral infections after hematopoietic cell transplantation.
PMID 16305617·Pediatr Transplant·2005
6-review
Optimization of quantitative detection of cytomegalovirus DNA in plasma by real-time PCR.
PMID 15004066·J Clin Microbiol·2004
4-observational
Recent advances in the prevention of CMV infection and disease after hematopoietic stem cell transplantation.
PMID 15125702·Pediatr Transplant·2004
6-review
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
PMID 14506657·Biol Blood Marrow Transplant·2003
6-review
Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity.
PMID 12393659·Blood·2003
8-other
Phase 1 evaluation of the respiratory syncytial virus-specific monoclonal antibody palivizumab in recipients of hematopoietic stem cell transplants.
PMID 11443562·J Infect Dis·2001
3-trial
Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
PMID 11464977·Biol Blood Marrow Transplant·2001
3-trial
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy.
PMID 14644993·Blood·2004
6-review
Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
PMID 19450754·Biol Blood Marrow Transplant·2009
4-observational
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.
PMID 19450762·Biol Blood Marrow Transplant·2009
8-other
Comparison of conventional and molecular detection of respiratory viruses in hematopoietic cell transplant recipients.
PMID 19453994·Transpl Infect Dis·2009
4-observational
Timing and severity of community acquired respiratory virus infections after myeloablative versus non-myeloablative hematopoietic stem cell transplantation.
PMID 19644142·Haematologica·2009
8-other
The contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.
PMID 19203725·Biol Blood Marrow Transplant·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1100 FAIRVIEW AVE N
SEATTLE, WA 98109 - Phone
- (206) 667-4898
Quick Facts
- NPI
- 1033310222
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile